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ABSTRACT 
Cell shape is critical for the proper function of every cell in every tissue in the body. This is 
especially true for the highly morphologically diverse neural and glia cells of the central 
nervous system. The molecular processes by which these, or indeed any, cells gain their 
particular cell-specific morphology remain largely unexplored. To identify the genes involved 
in morphogenesis of the principal glial cell type in the vertebrate retina, the Müller glia (MG), 
we used genomic and CRISPR based strategies in zebrafish (Danio rerio). We identified 41 
genes involved in various aspects of MG cell morphogenesis and revealed a striking 
concordance between the sequential steps of anatomical feature addition and the 
expression of cohorts of functionally related genes that regulate these steps. We noted that 
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the many of the genes preferentially expressed in zebrafish MG showed conservation in glia 
across species suggesting evolutionarily conserved glial developmental pathways.  
Key Words: morphogenesis, zebrafish, Müller glia, transcriptome, CRISPR 
Main Points:  
- Müller Glia morphological features are added at distinct stages 
- Unique genes are enriched at each stage of Müller Glia morphogenesis 
- Müller Glia morphological features arise from distinct gene expression patterns 
- Müller Glia morphogenesis is controlled by conserved genetic programs 
1. INTRODUCTION 
The genetic control of postmitotic cell shapes is very poorly understood, especially for the 
cells making up the central nervous system (CNS), i.e. the neurons and glia. These cells 
assume an immense variety of cell type-specific morphologies necessary for building their 
precise connections during development (Kandel, 2013). Glial cells have elaborate 
morphologies that facilitate their ability to make precise contacts with specific partner 
neurons, blood vessels and other glia (Kettenmann and Ransom, 2013). For example, 
astrocytes, the most abundant glial type in the CNS, emanate numerous fine projections to 
contact up to 2 million synapses per cell (Araque et al., 1999). These glial projections 
provide support to their synaptic partners by expressing specific molecules necessary for 
energy metabolism, neurotransmitter recycling and ionic homeostasis (Khakh and 
Sofroniew, 2015). Altered glial morphology is a common pathological feature of neurological 
disorders and may significantly contribute to neuronal dysfunction and degeneration (Burda 
and Sofroniew, 2014). Loss of correct glial morphology and subsequent neuronal support is 
associated with many psychiatric and neurodegenerative conditions (Bringmann and 
Reichenbach, 2009; Jadhav et al., 2009; Pfrieger, 2009; Reichenbach and Bringmann, 
2013).  Despite their importance, it is not well understood how glial cells establish their 
overall morphology or their precise synaptic contacts during CNS development. 
The radially oriented glial cells in the retina were first described more that 150 years ago 
(Muller, 1851), and were later named Müller glia (MG) in honor of their discoverer.  MG are 
astonishingly complex and show several elaborate anatomical features that are necessary 
for precise contact with distinct retinal neurons and membranes. MG are present in all 
vertebrate retinas and share a conserved set of well-aligned and layered anatomical 
features, which were first noted by the great neurohistologist Ramon y Cajal (Cajal, 1892). 
These features are: 1) their cell bodies sit in the middle cellular layer of the retina - the inner 
nuclear layer (INL) (Figure 1A); 2) their central radial processes span the width of the retina 
making contact with both the outer to the inner limiting membranes (OLM and ILM); 3) fine 
branches emerge laterally from these central stalks extending differentially into the two 
synaptic neuropils, known as the outer and inner plexiform layers (OPL and IPL) 
(MacDonald et al. 2017; Uga and Smelser 1973). Additionally, the MG cells in the mature 
retina are evenly spaced with their processes arranged in highly ordered mosaics, with little 
overlap between the cellular domains of neighboring MG cells (Williams et al., 2010; Wang 
et al., 2017). This network of mature MG morphology facilitates their contact with potentially 
every neuron and every synapse in the retina.  
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The cellular and molecular events underpinning these diverse anatomical features are 
completely unknown.  Yet the conserved, layered, cellular anatomy of MG cells (see Fig 1A) 
makes them an excellent cell type to investigate the genes involved in cellular 
morphogenesis (Cajal, 1892; Reichenbach and Reichelt, 1986; Kolb et al., 2001; Williams et 
al., 2010; MacDonald et al., 2015, 2017; Wang et al., 2017). In this study, we combined 
temporal dissection of the MG developmental process in zebrafish with transcriptomics to 
identify genes that are significantly enriched in the MG at six key stages of development. 
Using CRISPR based reverse-genetic screening of 66 candidates we were able to implicate 
41 genes in various aspects of MG cell morphogenesis. Remarkably, these studies also 
reveal that the sequential steps of anatomical feature addition in MG were regulated by 
successive expression of cohorts of functionally interrelated genes.  Furthermore, we 
identified a conserved Pax2a dependent regulome, previously implicated in vertebrate 
kidney and invertebrate retinal glia morphogenesis, that controls many aspects of zebrafish 
MG differentiation.  Together, our results provide an extensive genetic study that represents 
the first critical step to furthering our understanding of glial shape formation with potential 
relevance to general post-mitotic cell shape acquisition.   
2. MATERIALS AND METHODS 
2.1 Animals 
Adult zebrafish were maintained and bred at 26.5°C. Embryos were raised at 25°C–32°C 
and staged based on (Kimmel et al., 1995) in hours post fertilization (hpf). Embryos were 
treated with 0.003% phenylthiourea (PTU, Sigma) from 10hpf to prevent pigmentation. All 
animal work was approved by the Local Ethical Review Committee at the University of 
Cambridge and performed according to the protocols of project license PPL 80/2198. 
2.2 Transgenic Lines 
Transgenic lines Tg(atoh7:gap43-mRFP1)cu2 (Zolessi et al., 2006), Tg(GFAP:GFP) 
(Bernardos and Raymond, 2006), Tg(TP1:Venus-Pest) (Ninov et al., 2012). 
2.3 FACS, RNA-seq and Bioinformatics 
To obtain tissues for FACS and transcriptomic analysis 20-40 whole eyes of the transgenic 
zebrafish line Tg(GFAP:GFP) were dissected from each developmental time point (48, 60, 
72, 96, 120 and 192 hpf) and washed several times to remove debris in L-15 (Leibovitz’s L-
15 Medium).  Eyes were then incubated in Trypsin-EDTA 0.25% (Sigma) at 37C for 15min, 
washed several times and dissociated using FBS coated pipette tips in Calcium-free medium 
(116.6 mM NaCl, 0.67 mM KCl, 4.62 mM Tris, 0.4 mM EDTA).  Single cell suspensions were 
sorted on a Beckman Coulter MoFlo to capture Muller glia (GFP) and control (C) retinal 
tissue (non-GFP). Cells were sorted into lysis buffer, and RNA was immediately extracted 
using the RNeasy mini kit (Qiagen). RNA concentration and qualities were assessed on an 
Agilent Bioanalyzer, and RNA amplification and cDNA synthesis were performed with the 
Ovation RNA Amplification System V2 (NuGEN) using the manufacturer’s protocol. Nextera 
library preparations were performed using the Nextera DNA library kit according to the 
manufacturer's directions and sent to the Sanger Centre for sequencing. 
Sequence files (GEO accession GSE120275) were paired, trimmed and aligned using 
Hisat2 to the zebrafish genome (version: Zv9) and RNA-seq bioinformatic and statistical 
analysis was performed in R using the Bioconductor, FeatureCounts, Rsubread, limma, 
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DESeq2, DEFormats, pheatmap, ggplots, org.Dr.er.db, and EdgeR packages. For 
enrichment analysis, trimmed-means-of-m (TMM) analysis was combined with Benjamin-
Hochberg correction to correct false discovery rate (FDR). Cross-species gene conversions 
were performed using Ensembl (Biomart) by using zebrafish (GRCz11) or fly (BDGP5) gene 
symbols as the input filter, and Ensembl gene ortholog (mouse) readout attributes. Overlaps 
were between separate datasets were then quantified using Venny (2.1.0).  Statistical 
significance of gene overlaps was calculated using Fisher’s exact tests and corrected to 
discount multiple testing errors using the strict Bonferroni method. Gene Ontology analysis 
and statistics were performed using Gene Ontology Consortium (Ashburner et al., 2000; The 
Gene Ontology Consortium, 2017). 
2.4 Embryo Manipulations 
For blastomere transplantations, high- to oblong-stage embryos were dechorionated by 
pronase digestion (Sigma), placed in agarose molds, and between 5 and 30 blastomeres 
were transferred between Tg(TP1:Venus) embryos to wild type embryos using a glass 
capillary connected to a 2 ml syringe. Embryos were grown on dishes coated with 1% 
agarose in 0.04% PTU overnight until imaged by confocal microscopy.  
 2.5 sgRNA design and Reverse Genetic Screen 
The sgRNA design and strategy are primarily based on the methods from Shah and 
colleagues (Shah et al., 2016). Briefly, each guide RNA was designed using the ChopChop 
design tool (Labun et al., 2016) at chopchop.cbu.uib.no/index.php. For each gene, the two 
gRNAs with minimal predicted off-target sites were selected and co-injected.  In the first 
screen we picked the two targets with the highest overall rankings in the first exon, while in 
the second and third screens we used the highest-ranking targets for the first and last exon 
of each gene. Template DNA was synthesized by in vitro transcription of a two oligo PCR 
method. For this, an oligo scaffold containing the RNA loop structure 
5'[gatccgcaccgactcggtgccactttttcaagttgataacggactagccttattttaacttgctatttctagctctaaaac]3' 
required for Cas9 was synthesized and used for the syntheses of all gRNAs (Extended data 
table 2). Next, a unique oligo containing the T7 promoter, the 20 nucleotides gRNA, and 20 
bases of homology to the scaffold oligo was synthesized. PCR amplification of these 
annealed oligos sequence was created using Phusion master mix (New England Biolabs, 
M0531L) with 10uM scaffold and gRNA for 40 cycles in a thermal cycler. This PCR product 
was purified (PCR purification kit - Qiagen) and used as a template for the in vitro 
transcription reaction (T7 megascript – Ambion). RNA was purified on columns (Zymo 
Research, D4014) and injected using 100pg of each gRNA (200ng total) with 1200pg of 
Cas9 encoding mRNA.  
2.6 Immunostaining and Microscopy  
Imaging of CRISPR injected embryos for each screen was carried out on fixed embryos at 
120hpf (4% paraformaldehyde). Embryos were mounted in 1% low melting point agarose 
and positioned to allow for imaging of the retina in situ.  
For immunohistochemistry CRISPR injected and mutant embryos were fixed at 120hpf in 4% 
paraformaldehyde overnight at 4°C, washed in PBS and then stored in MeOH at -20°C. 
Samples were re-hydrated in a MeOH:PBS series (3:1, 1:1, 1:3) followed by three PBST 
(PBS + 0.05% Triton-X100) washes.  Rehydrated whole embryos were incubated in GFP-
Booster Atto488 (1:500, Chormotek) for 2hrs at RT and were then mounted on slides with a 
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coverslip bridge (to prevent crushing the tissue) in Prolong Diamond (Invitrogen) and allowed 
to cure at room temperature overnight before imaging. For Pax2 staining samples were 
incubated in Rabbit anti-Pax2 (1:200 ; previously Covance catalog# PRB-276P) and goat 
anti-rabbit conjugated Alexa Fluor 555 1:500 (Invitrogen) at 4°C overnight and mounted as 
above. 
Laser scanning confocal imaging was performed using an Olympus FV1000 microscope with 
a 60 X oil objective (1.35 NA). For live imaging, optical sections at 0.5–1 µm separation were 
taken to cover the region of the retina containing the cells of interest (between 10 and 30µm) 
every 15 minutes over 12 hours. For CRISPR screening, 0.5um optical sections of 
transverse sections near the middle of the retina on whole embryos, which were orientated 
so that the outer surface of the eye was closest to the coverslip, as described previously 
(Das et al., 2003). Confocal data were analyzed and processed using Volocity (PerkinElmer) 
and ImageJ/FIJI (NIH). 
2.7 Phenotype analysis 
For phenotype analysis, injections of gRNAs were made in three replicate experiments.  
Control animals we injected guide RNAs to Slc24a5, which resulted in normal MG 
morphology and loss of animal pigment confirming that our CRISPR strategy was effective 
(Supp figure 4A).  Similar to previous CRISPR screening techniques, control and 
experimental injections produced between ~30% and ~55% embryonic lethality with 
phenotypes observable in around 95% of the surviving animals (Supp Figure 4F; Shah et al., 
2016; Wu et al., 2018).  We also generated F1 mutant lines for several CRISPR mutants 
(pax2a, nphs1, kirrela, Itga5, Itga6, wt1b, cadm1b and cadm4) and confirmed that CRISPR 
mutation was highly specific (by DNA sequencing) and 100% penetrant (by phenotype 
similarity) (Supp Figure 4E; Shah et al., 2016).  Finally, pax2a CRISPR mutation was verified 
by the fact that Pax2 immunostaining at 72hpf shows positive nuclei in control animals but 
mostly absent in F0 CRISPR injected fish and completely absent in F1 pax2a mutants (Supp 
figure 4B-D). 
 
Phenotype counts were done on between 45 and 56 injected animals for each mutant (Supp 
Table 4) using un-flattened (un-processed) z-stack transverse images of retinas in situ in 
whole embryos. Each sample’s MG features were scored throughout the tissue using the 
following criteria to make a decision on the presence or absence of particular defects: Soma 
position: Abnormal MG soma position basally or apically, adjacent to the IPL, or completely 
displaced from the INL; OLM:  Large breaks or the complete absence of the OLM; ILM: 
Large breaks or the complete absence of the ILM;  IPL: Altered thickness, failure to 
elaborate, or abnormal elaboration of the IPL; OPL: Failure or abnormal elaboration of the 
OPL; Tiling: Significant spacing disruptions (large gaps or multiple overlaps) of MG cell 
bodies, and/or MG projections including those in the IPL and OPL. Mutant phenotype counts 
were subjected to Fisher’s exact tests to quantify significance with Bonferroni correction to 
eliminate multiple testing errors (121 for Screen 1, 174 for Screen 2, 120 for screen 3). 
3. RESULTS 
3.1 The anatomical development of MG can be broken into sequential steps of feature 
addition. 
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It is known that Notch signaling is essential for MG cell specification (Dorsky et al., 1995; 
Ohnuma et al., 1999; Vetter and Moore, 2001) and in the Tg(TP1:Venus) transgenic line 
(Ninov et al., 2012), the Notch-responsive element TP1 drives expression of the fluorescent 
protein, Venus, allowing MG cells to be followed from the time of their initial specification in 
zebrafish at ~60 hpf (MacDonald et al., 2015). By transplanting blastomeres from the 
transgenic zebrafish line into wild-type hosts, we were able to visualize the sequential steps 
of MG morphogenesis in zebrafish in vivo (Figure 1B). At 60hpf, the MG cell bodies begin to 
migrate basally to their stereotypic position in the middle of the INL of the retina (MacDonald 
et al., 2015). By 72hpf, MG begin to expand their apical processes and basal endfeet to 
confluently fill the surfaces of the OLM and ILM respectively. At this time, they also begin to 
extend dynamic filopodia from their central stalks, which identify the OLP and the apical and 
basal limits of the IPL.  By 96hpf MG in zebrafish elaborate fine processes with the plexiform 
layers (Williams et al., 2010). The last step that we investigated in this process is that MG 
cells space themselves out across the retina such that they are evenly distributed across the 
retina with little to no gaps or overlaps (Williams et al., 2010; MacDonald et al., 2015).  
Homotypic repulsive cell interactions are thought to account for this (Bushong et al., 2002; 
Williams et al., 2010), as focal ablation of MG cells results in nearby MG cells extending 
processes to fill in the spaces previously occupied by the ablated MG cell (Williams et al., 
2010). Thus, by the time robust vision commences in zebrafish, at about 120hpf (Biehlmaier 
et al., 2003), these cells have gained the full set of the conserved cell-specific anatomical 
characteristics that Cajal originally identified.  
3.2 Transcriptomic analysis of key stages in MG morphogenesis reveals gene 
ontology differences 
To search for genes involved in MG cell morphogenesis, we FACS-sorted MG at specific 
times (48hpf, 60hpf, 72hpf, 96hpf, 120hpf, and 192hpf) that span the morphogenetic process 
outlined above and identified genes expressed preferentially at each of these time points 
(Figure 1C). Hierarchical clustering and principal component analysis of these data reveal 
that minimal differences in three experimental replicates of these individual time-points 
(Figure 1D). However, significant differential gene expression is notable throughout MG cell 
differentiation (Supp Table 1). Importantly, clustering all time-points by Trimmed Means of M 
(TMM) differential gene enrichment, shows that several of the top 100 genes have previously 
been associated directly with MG cells or other glia (Figures 1C, Supp table 2) (White and 
Neal, 1976; Riepe and Norenburg, 1977; Eisenfeld et al., 1984; Lehre et al., 1997; Lehre and 
Danbolt, 1998; Saari et al., 2001; Dahlin et al., 2009; Zong et al., 2010; Jo et al., 2015). 
Overrepresentation of the gene ontology terms revealed several terms that are frequently 
associated with differentiation including; transcription, cell cycle exit, cell structure, adhesion, 
metabolism, growth signaling, membrane transport, and cation activity.  
 
The GO terms for each developmental stage revealed dynamic changes in the biological and 
molecular functions of differentially expressed genes throughout MG development (Figure 
1E, Supp table 3). Focusing, for example, on the gene ontologies that make intuitive sense, 
we find at 48hpf cell cycle genes were over-represented, at 60hpf it was genes involved in 
cell growth, at 72hpf cell signaling, at 96hpf adhesion, and at 120hpf and 196hpf 
physiological function.  Other gene ontologies involved in metabolism and transport also 
changed expression over this time course. 
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3.3 CRISPR analysis of phenotypes during MG development 
To determine if the temporal expression of these genes is important for discrete stages of 
MG morphogenesis, we used hierarchical clustering and TMM differential expression 
analysis to identify genes that first became enriched at specific time points and remained 
enriched until 192hpf (i.e. 48-192hpf, 60-192hpf, 72-192hpf and 96-192hpf) (Supp Table 4).  
We then limited our attention to those genes that code for proteins that seemed likely 
candidates to have an impact on cell morphogenesis (Supp Table 4), and knocked out these 
genes by injecting Cas9 mRNA and candidate-specific gRNAs (Shah et al., 2016; Wu et al., 
2018).  The background was always the Tg(GFAP:GFP) transgenic line (Bernardos and 
Raymond, 2006) so that we could assay morphological defects specifically in MG cells in F0 
embryos at 120hpf (see methods for CRISPR screening validation). The CRISPRed fish all 
continued to express the GFAP:GFP transgene in MG cells, suggesting initial glial 
specification is unaffected in any of the F0 CRISPR mutants. Yet many of the F0 CRISPR 
mutants produced clear defects in MG cell anatomy. Analyzing 45 to 60 injected animals we 
scored the frequency that obvious phenotypes were observed in accordance with the 
particular criteria for each morphological feature (see Methods, Supp table 5).   
48-192hpf. Mutants in genes that were enriched from 48-192hpf (nav1b, f8, and cdhr1) 
produced irregularly shaped MG cells with significant defects in many of the cells 
conserved morphological features (Figure 2A-D; Supp figure 1B, C).  
60-192hpf. Genes enriched from 60-192hpf with mutant phenotypes include sptbn5, 
myo6b, xirp1, and map1ap (Figure 2A). Interestingly none of them showed significant 
apico-basal soma positioning defects though they had several other defects (Figure 2B, 
E; Supp figure 1D-H).  
72-192hpf. Genes enriched from 72-192hpf with significant mutant phenotypes include 
lamb2, fat1b, cadm1b, and sox10 (Figure 2A). These displayed defects in still fewer and 
later aspects of MG cell morphogenesis (Figure 2B, F; Supp figure 1G – I).  
96-192hpf. Genes enriched from 96-192hpf with significant mutant phenotypes include 
nfat5c, snx19a, and nphp1 (Figure 2A). All these only showed defects in MG cell tiling 
most notably in the spacing of the soma and/or overlapping inner and outer plexiform 
layers. (Figure 2B, G; Supp figure 1J, K).  
The frequency of defects in each MG compartment was independently quantified to 
determine each overall mutant phenotype and 14 of the 21 candidates tested in the initial 
screen had significant defects (figure 2H, Supp table 5,). These results indicate a gradation 
of phenotypes such that genes enriched at early stages are involved in multiple defects in 
MG cell morphogenesis whereas those enriched later genes have roles that are restricted in 
late developing features of MG.  We next asked whether genes enriched during more 
narrowly restricted time windows would have more refined morphogenetic defects (Figure 
3A, Supp table 4, Supp figure 2K). For this, we used hierarchical clustering and TMM 
analysis to identify the genes that were only enriched at a single individual time point in MG. 
48hpf. Two genes enriched at 48hpf, lamb4 and timp2b showed significant defects in 
apical-basal soma positions (Figure 3B, C; Supp figure 2B). Apical-basal soma defects 
were also seen in mutants of two other genes that were transiently enriched at 48hpf: 
prtm6a and vwde (Figure 3B; Supp figure 2C, D). However, prmt6 mutants also show 
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defects in ILM formation, and vwde mutants also show defects in OPL formation (Figure 
3B, Supp figure 2C, D; Supp table 4).  
60hpf. Genes that were overrepresented at 60hpf with mutant phenotypes showed 
defects in later stages of morphogenesis (Figure 3B). dcaf8 mutants have OPL and OLM 
defects (Figure 3D; Supp table 4), apcdd1l mutants have defects in IPL and  MG tiling 
(Supp figure 2E; Supp table 4), and sypb mutants show defects in OPL, OLM and tiling, 
(Supp figure 2F; Supp table 4).  
72hpf. Mutants in genes enriched at 72hpf preferentially affected later steps of 
morphogenesis: mmp28 mutants affected the ILM (Figure 3E; Supp table 4), and cux2b 
mutants affected the ILM and IPL in (Figure 3B; Supp figure 2G).   
96hpf. Similarly, mutants in genes enriched at 96hpf, cx31.7, egr1, and slitrk2, showed 
subtle defects in the IPL and OPL, and tiling (Figure 3A, F, G; Supp figure 2H; Supp table 
4).  
120hpf. Finally, mutant in genes preferentially expressed at 120hpf, including icn2, 
mpp6b and cacnb2a (Figure 3A) produce nothing more than tiling defects, (Figure 3H; 
Supp figure 2G; Supp table 4; Supp table 4).  
The frequency of defects in each MG compartment was again quantified for each mutant 
with 15 of the 29 candidates in this second screen showing statically significant phenotypes 
(figure 3I, Supp table 5). Together, these data reveal a striking correlation with the type of 
phenotype seen, the temporal expression of specific genes, and the developmental time 
course of the addition of specific anatomical features.  This suggests that particular features 
of cellular anatomy invoke the transcription of specific genetic repertoires that work at 
particular periods of development.   
3.4 Conserved regulators of glial morphogenesis 
We noted that a large fraction of the genes identified proved to be essential for MG cell 
morphogenesis, as well as many that we did not test using CRISPR analysis, were highly 
conserved regarding their expression in glial cells across species (Figure 4A; Supp figure 
3A; Supp table 4).  For instance, from our transcriptome control and MG genes have similar 
levels of overlap with zebrafish whole CNS genes (Figure 4A; Drew et al., 2008). However, 
in cross-species comparisons, we find a highly significant overlap of the MG orthologs with 
another zebrafish, three mice and a fly retinal glia datasets, while the control (mixed retinal 
population) tissue overlap has no significant difference in the overlap between MG and the 
whole CNS(Figure 4A; Roesch et al., 2008; Qin et al., 2009; Nelson et al., 2011; Macosko et 
al., 2015; Sifuentes et al., 2016; Charlton-Perkins et al., 2017).  Some of these highly 
conserved genes are known to be involved in glial differentiation.  For example, Pax2a (from 
the Pax2/5/8 family) and the integrins (Itga5, Itga6, Itgb1a) are expressed in many glial cells 
and mutants in all of these genes also resulted in defects in many aspects MG cell 
morphology (Figure 4B; Supp Figure 3B-E; Supp table 4; Supp Figure 3H; Charlton-Perkins 
et al., 2011, 2017; Putaala et al., 2001; Quaggin, 2002; Ambu et al., 2015; Dzyubenko et al., 
2016).  Remarkably, analysis of the transcriptome of MG cells in pax2a mutants shows that 
60% of the genes that affect MG cell morphogenesis in our study have significant changes of 
expression (Figure 4C; Supp Table 4). In addition, the differentially expressed genes in 
pax2a mutant MG cells show a significant enrichment of GO terms related to cell 
morphology, adhesion and differentiation (Figure 4D; Supp table 5). These results suggest 
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that Pax2 is a key regulator of MG morphogenesis.  We also found several other families of 
conserved glial genes involved in various aspects of MG morphogenesis: for instance, 
nephrins (Supp Figure 3C-D), and the Cadm family of cell adhesion molecules (Supp figure 
3G - I). We quantified MG compartment defect frequency for all of these and found 11 with 
statistically significant phenotypes (Figure 4H, Supp Table 5,). Together, these results 
suggest that there are many conserved molecular genetic principles of glial cell 
morphogenesis.  
4. Discussion 
The post-mitotic temporal addition of layered morphological features in MG offers a unique 
opportunity to genetically dissect the poorly understood process of cell morphogenesis in 
zebrafish where development is rapid and the embryos is transparent. Indeed, in mice, MG 
differentiation begins at P0 and lasts beyond P9 and many of the details of this process have 
not yet been studied (Nelson et al., 2011).  However, similarly to the zebrafish MG 
differentiation, it has been noted that the ILM/OLM formation occurs prior to P7, IPL 
elaboration begins around P7, and OPL elaboration begins around P8 (Wang et al., 2017).  
Using our approach combing cell sorting, transcriptomics, and CRISPRs, we identified many 
of key players in fish MG differentiation, and linked them to specific temporal windows of 
action, during which morphological features are added. We therefore suspect that future 
studies in mammal MG differentiation will find that many orthologous genes with similar 
functions. 
 
The temporal transcriptome and bioinformatic analysis here are the first in-depth dataset of 
cell morphogenesis.  Sequencing technologies have improved dramatically in the past few 
years such that combined with bioinformatic normalizations and false discovery rate (FDR) 
correction there is little question about the timing and enrichment of MG genes found here 
(Salk et al., 2018).  However, there is ultimately information that we cannot get from 
transcriptomics that needs to be included in future morphogenesis studies to improve our 
understanding of glial morphogenesis.  One example of this is that of the integrin pathway 
which is already known to regulate the placement and morphology of glia across the nervous 
system (Dzyubenko et al., 2016).  The integrin complex is made up of alpha and beta 
subunits that serve as signaling and adhesive attachments between the cell and the 
extracellular matrix (Giancotti and Ruoslahti, 1999). Here we find three subunits, two alpha 
(Itga1a, Itga1b) and one (Itgb1a) subunit (Figure 4E-F) that together have phenotypes in 
every MG compartment.  However, the alpha-subunits produce phenotypes in more distinct 
MG compartments than the beta-subunit suggesting that beta-subunits are more broadly 
expressed across the cell membrane.  This fits well with the previous knowledge that integrin 
complexes are made of different subunits depending on the part (apical or basal) of the cell 
surface they reside (Lowell and Mayadas, 2012; Salk et al., 2018). Thus, future studies using 
focusing of these and other cell adhesion families identified in this study should provide a 
more detailed understanding of their roles in glial cell morphology.  
 
CRISPR/Cas9 technology has added an invaluable tool that is quickly replacing traditional 
morpholino analysis in zebrafish and other model organisms.  If done carefully, it has very 
few off-target effects, and its accuracy is currently undisputed (Anon, 2018).  For these 
reasons, it is unlikely that we have many off-target effects in this study.  This possibility 
seems even less likely considering the high incidence and the morphological specificities of 
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the MG phenotypes seen. Our screening also reliably produced the same F0 morphological 
defects in the MG population, and we have also confirmed these in some several F1 
generations (Supp Fig 4E).  It should be noted that the F0 CRISPR mutants are by nature 
mosaic, and the specific morphologies of the MG defects seen in our F0 screens need to be 
examined in fully mutant lines. Such lines can also be used in studies to test the cell-
autonomous vs. non-autonomous aspects of these phenotypes by transplanting blastomeres 
from mutant lines into normal hosts and vice-versa. Indeed, none of the particular 
phenotypes found in this study was quantitatively or mechanistically investigated further, as 
this did not seem reasonable in an F0 screen. More detailed quantitative and mechanistic 
investigations into these phenotypes will be the subject of future studies.   
 
The high level of genetic conservation of glia in the animal kingdom suggests there may be 
basic principles of glial biology (Charlton-Perkins et al., 2017), and the finding here that 
several conserved genes are involved during particular temporal windows of MG 
morphogenesis, suggest that there may also be conserved programs of differentiation . A 
recent study has implicated some genes found here in mouse MG morphology and tiling 
including Rbx2, Dab1, and SOCS7 (Fairchild et al., 2018).  Another excellent example of this 
conserved function is Pax2, which in the eye is primarily known for its function in optic stork 
formation, and whose expression has been noted in mature MG of chick but not guinea pigs 
or dogs (Boije et al., 2010; Stanke et al., 2010). Pax2 and Wt1 are also crucial for cellular 
patterning through their regulation of the Nephrins in the brain, kidney and fly retinal glia 
(Putaala et al., 2001; Quaggin, 2002; Ambu et al., 2015; Wagner et al., 2002; Ambu et al., 
2015; Cagan, 2003; Bao and Cagan, 2005; Fu and Noll, 1997; Flores et al., 1998; Charlton-
Perkins et al., 2011, 2017).  Our transcriptomes indicate that many Nephrins are also 
temporally enriched in zebrafish MG, they affect glial morphology, and their expression is 
Pax2a dependent (Supp Table 4).  Taken together, our data suggest that Pax2, Wt1 and the 
nephrins are part of a conserved regulome that controls cell shape and patterning in multiple 
biological contexts.  It would, therefore, be fascinating to understand the genetic relationship 
between Nphp1 and other "kidney related" genes in future more in-depth compound genetic 
studies of all the above genes.  
Perhaps the most remarkable finding of this study is the enrichment of genes during narrow 
windows that regulate the differentiation of discrete MG compartments that develop in those 
time windows, although in retrospect, it seems obvious that pathways that come on late in 
MG development could not possibly affect early stages of MG development, etc. Single-cell 
transcriptomic studies have shown a level of background variability between individual cells 
(Tasic, 2018). However, in the context of this study, we find that the MG follow rather precise 
changes in gene expression that correlate MG compartment differentiation.  Our analyses 
show that successive steps of cell morphogenesis correlate with the timing of the expression 
of cohorts of conserved interrelated genes that have roles in generating the particular 
anatomical features of these cells, suggesting that a sequence of genetic regulomes govern 
stepwise cellular morphogenesis in this system.  We hope that this work which suggests the 
development MG can be approached stage-by-stage and feature-by-feature, each stage and 
feature with its own development genetic programs, will provide a foundation for future 
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Figure 1: Temporal MG cell morphology and gene expression. A) Diagrammatic 
representation of the retina within the eye showing the positioning of MG cells.  B) 
Tg(TP1:Venus) transplanted MG cells showing the time course of MG cell differentiation that 
gives rise to the distinct MG compartments (OLM – outer limiting membrane, OPL – outer 
plexiform layer, INL – inner nuclear layer, IPL – inner plexiform layer, ILM – inner limiting 
membrane). C) Heatmap (relative expression values by sample - CPM) of top 100 
significantly expressed genes in MG (GFAP-GFP cells) compared to control (GFP negative 
cells) retinal cells (known glial genes are green and * indicates previous reported expression 
in MG) (see Supplemental table 1 for normalized enrichments).  D) Hierarchical clustering of 
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samples used for RNA-seq demonstrating consistency between the three replicates used for 
each time point (MG- GFAP-GFP sorted cells, C – GFP negative control tissue) E) 
Representative gene ontology proportions of MG genes enriched at 48, 60, 72, 96,120, and 
196hpf. 
  
Figure 2: Temporal gene expression dictates MG cell morphologies. A) Heatmap to 
show the relative gene expression for genes tested. B) Summary of phenotypes observed 
for genes enriched across windows of MG cell differentiation. Red – phenotype, blue – no-
phenotype. C) slc24a5 CRISPR injected control animals have normal MG cell morphology 
that extends from the apical to the basal surfaces, forming the ILM (inner limiting membrane) 
and OLM (outer limiting membrane) on either side. MG cells are also regularly tilled across 
in the eye with their cell bodies mostly restricted to the middle of the INL (inner nuclear layer) 
and are highly branched within the IPL (inner plexiform layer) and OPL (outer plexiform 
layer). D) nav1b CRISPR injected animals have defects in apico-basal cell body position in 
the INL (inner nuclear layer), OLM (outer limiting membrane), OPL (outer plexiform layer), 
tiling, IPL (inner plexiform layer) and ILM (inner limiting membrane). E) mapab1 CRISPR 
injected animals have defects in OLM, OPL, and IPL. F) fat1b CRISPR injected animals 
have defects in OPL and IPL defects. G) nphp1 CRISPR injected animals have defects in 
MG cell tiling. H) Frequency (%) of phenotypes observed in each MG compartment in F0 
CRISPR screen 1. Scale bars - 8um. 
  
Figure 3: Discrete gene expression regulates MG cell compartment morphology.  A) 
Heatmap to show the relative gene expression for genes tested.  These were all screen in 
F0 CRISPR injected mutants. B) Summary of phenotypes observed for genes enriched 
across windows of MG differentiation. Red – phenotype, blue – no-phenotype. C) lamb4 
mutants have defects in the apico-basal distribution of MG cell bodies only. D) dcaf8 mutants 
have defects in the OLM and OPL.  E)  mmp28 CRISPR injected mutants have defects in 
the ILM only. F) egr1 mutants have defects in the IPL and OPL. G) slitkr2 mutants have 
defects in the OPL layer only. H) icn2 mutants have tiling defects only. I) Frequency (%) of 
phenotypes observed in each MG compartment in F0 CRISPR screen 2. Scale bars - 8um. 
  
Figure 4: A set of highly conserved genes that affect MG cell morphology. A) Overlap 
of zebrafish MG enriched genes with previously reported MG transcriptomes from zebrafish, 
mouse and fly (Roesch et al., 2008; Qin et al., 2009; Nelson et al., 2011; Macosko et al., 
2015; Sifuentes et al., 2016). MG - genes enriched in GFAP-positive cells; C – genes 
enriched in non-GFP positive cells; * - indicates significance (Bonferroni adjusted p-value 
<0.001) by Fisher's exact test. B) pax2a CRISPR injected animals have highly disorganized 
retinas with breaks in the OLM and ILM, abnormal tiling and apico-basal distribution of the 
cell bodies, as well as much less branching in the IPL and OPL (see Supp table 4 for 
details). C) Percentages of genes used in this study that either had or did not have a 
phenotype. * - indicates significance by Fisher’s exact test. D) GO terms for the top 500 
genes significantly (adjusted p < 0.05) up or down-regulated pax2a mutants. E) itga5 
CRISPR injected animals have defects on the basal side of MG specifically in the ILM and 
IPL. F) Itag6 CRISPR injected animals have defects on the apical side of the cell in the OLM 
and OPL. G) F0 itb1a CRISPR injected animals have defects in cell body tiling and apico-
basal position, as well as in OLM and ILM. H) Frequency (%) of phenotypes observed in 
each MG compartment in F0 CRISPR screen 3. Scale bars - 8um. 
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Supplemental figure 1: Phenotypes of gene mutants enriched over windows of MG 
cell differentiation. A) slc45a5 controls have no observable MG phenotype. B) f8 mutants 
have defects in cell body position, OLM, ILM, IPL, OPL, and tiling. C) cdhr1 mutants have 
defects in cell body position, OLM, ILM, IPL, OPL, and tiling. D) sptbn mutants have defects 
in OLM, IPL, OPL, and tiling. E) mapa1b mutants have defects in OLM, IPL, and OPL. F) 
xirp1 mutants have defects in OPL and tiling. G) lamb2 mutants have defects in ILM, IPL, 
and tiling. H) Cadm1b mutants have defects in ILM, IPL, OPL, and tiling. I) sox10 mutants 
have defects in IPL and tiling. J) nfat5 mutants have tiling defects. K) snx19a mutants have 
tiling defects. L) Percentages of individual phenotypes observed in all animals from this 
screen.  Dashed lines represent levels of significance from Fisher’s exact test after Boniforni 
multiple test correction (bottom - p<0.05, top – p <0.001). Scale bars - 8um. 
  
Supplemental figure 2: Phenotypes of gene mutants that are enriched at specific 
times of MG differentiation. A) slc45a5 controls have no observable MG phenotype. B) 
timp2b mutants have defects in cell body position. C) prmt6 mutants have defects in cell 
body position and ILM. D) vwde mutants have defects in cell body position, OLM, ILM, IPL, 
OPL, and tiling. E) apcdd1l mutants have defects in IPL and OPL. F) sypb mutants have 
defects in OLM, OPL, and tiling. G) Cux2b mutants have defects in ILM and IPL. H) cx31.7 
mutants have defects in tiling. I) Mpp6b mutants have defects in tiling. J) cacnb2a mutants 
have defects in tiling. H) Percentages of individual phenotypes observed in all animals from 
this screen.  Dashed lines represent levels of significance from Fisher’s exact test after 
Boniforni multiple test correction (bottom - p<0.05, top – p <0.001). Scale bars - 8um. 
 
Supplemental figure 3: Phenotypes of conserved highly conserved MG cell genes. A) 
Schematic representation of how highly conserved genes we bioinformatically identified. B) 
slc45a5 controls have no observable MG phenotype. B) timp2b mutants have defects in cell 
body position. C) nphs1 mutants have defects in ILM, IPL, and tiling. D) kirrela mutants have 
defects in cell body position and tiling. E) wt1 mutants have defects in cell body position, IPL, 
OPL, and tiling. F) mmp2 mutants have defects in OLM, ILM, and tiling. G) cadm4 mutants 
have defects in OPL, IPL, ILM, and tiling. H) Cadm1a mutants have defects in IPL and tiling. 
I) cadm2b mutants have defects in a cell body positing, IPL OPL and tiling. J) L) 
Percentages of individual phenotypes observed in all animals from this screen.  Dashed 
lines represent levels of significance from Fisher’s exact test after Boniforni multiple test 
correction (bottom - p<0.05, top – p <0.001).  Scale bars - 8um. 
 
Supplemental figure 4: CRISPR injection validation. A) Cas9 only injected F0 fish have 
normal pigmentation at 120hpf while those injected with Cas9 and the slc45a5 guide RNAs 
are mostly devoid of pigment. B) In control animals (GFAP:GFP) Pax2 is expressed in all 
MG by 120hpf. C) F0 pax2a CRISPR injected animals lack Pax2 expression in most, but not 
all MG.  D) F1 pax2a CRISPR injected animals Pax2 is absent from all MG.  E) F1 CRISPR 
mutants with confirmed mutations have notably similar defects to those identified in F0 
screen 3. F) Percentages of animals with lethality and phenotypes after injections. Scale 
bars - 8um. 
 
 
Supplemental Table 1:  TMM fold-change analysis of each MG cell developmental 
stage. 
Supplemental Table 2: Log counts per million for all samples 
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Supplemental Table 3:  Gene ontologies of each stage of MG cell differentiation. 
Supplemental Table 4: Summary of all genes used with gRNAs and phenotypes. 
Supplemental Table 5: TMM gene enrichments of Pax2a mutant MG cells 
 








